Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Here's what to know about our state’s laws, regulations and qualifying conditions, how to pursue a medical card, and how to ...

SolidRun, a leading developer and manufacturer of high-performance System on Module (SOM) solutions, Single Board Computers (SBC) and network edge solutions, today announced the launch of the ...

Elgin detectives were dubious when their chief suggested starting a true crime podcast to help find Karen Schepers. But it ...

NICE has separately evaluated cladribine for highly active multiple sclerosis in NICE’s technology appraisal guidance on cladribine for treating relapsing–remitting multiple sclerosis. The ...

Cladribine (Mavenclad) is available on the NHS as a possible treatment for active relapsing forms of multiple sclerosis in adults, if: if they have active relapsing–remitting multiple sclerosis, and ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Frexalimab was well tolerated and maintained disease control over two years in adults with relapsing MS in an open-label ...

That's because Greg, an engineer, rode his bike in the MS 150, a punishing ride, formerly between Houston and Austin. (The ...

SAN DIEGO -- Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive ...